A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution

Seon Mi Nam, Jee Whan Kim, Kyung Jin Eoh, Hye Min Kim, Jung Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, YoungTae Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective To evaluate the clinical and pathologic characteristics of patients who were diagnosed with ovarian Sertoli-Leydig cell tumors (SLCTs) in a single institution. Methods The medical records of 11 patients who were pathologically diagnosed with SLCTs beginning in 1995 in a single institute was reviewed. Results The median patient age was 31 years (range, 16 to 70 years). Patient International Federation of Gynecology and Obstetrics stages were IA, IC, and IIB in 3 (27.3%), 6 (54.5%), and 2 (18.2%) patients, respectively. Six patients (54.5%) had grade 3 tumors, 3 patients (27.3%) had grade 2 tumors, and 1 patient (9.1%) had a grade 1 tumor. Four patients without children underwent fertility-sparing surgery, and 7 patients had full staging surgery, including a hysterectomy and bilateral salpingo-oophorectomy, with a laparoscopic approach used in 3. Eight patients underwent pelvic lymph node dissection, and 8 patients were administered adjuvant chemotherapy consisting of bleomycin, etoposide, and cisplatin in 6 cases, a modified bleomycin, etoposide, and cisplatin regimen in 1 case, and a combined paclitaxel and cisplatin regimen in 1 case. Two patients died of disease and were re-diagnosed with Sertoli form endometrioid carcinoma. The other patients remain alive without recurrence at the time of reporting. Conclusion Our findings suggest that regardless of tumor stage or grade, ovarian SLCT patients have a good prognosis. Close observation and unilateral salpingo-oophorectomy would be beneficial for women who still wish to have children, while hysterectomy and bilateral salpingo-oophorectomy with adjuvant chemotherapy would be the optimal treatment in other cases. Furthermore, meticulous pathologic diagnosis is needed to develop a precise treatment strategy.

Original languageEnglish
Pages (from-to)39-45
Number of pages7
JournalObstetrics and Gynecology Science
Volume60
Issue number1
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Sertoli-Leydig Cell Tumor
Ovariectomy
Bleomycin
Etoposide
Adjuvant Chemotherapy
Hysterectomy
Cisplatin
Neoplasms
Endometrioid Carcinoma

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynaecology

Cite this

Nam, Seon Mi ; Kim, Jee Whan ; Eoh, Kyung Jin ; Kim, Hye Min ; Lee, Jung Yun ; Nam, Eun Ji ; Kim, Sunghoon ; Kim, Sang Wun ; Kim, YoungTae. / A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution. In: Obstetrics and Gynecology Science. 2017 ; Vol. 60, No. 1. pp. 39-45.
@article{c4ea04e77b544be897ae2988b9e6c6df,
title = "A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution",
abstract = "Objective To evaluate the clinical and pathologic characteristics of patients who were diagnosed with ovarian Sertoli-Leydig cell tumors (SLCTs) in a single institution. Methods The medical records of 11 patients who were pathologically diagnosed with SLCTs beginning in 1995 in a single institute was reviewed. Results The median patient age was 31 years (range, 16 to 70 years). Patient International Federation of Gynecology and Obstetrics stages were IA, IC, and IIB in 3 (27.3{\%}), 6 (54.5{\%}), and 2 (18.2{\%}) patients, respectively. Six patients (54.5{\%}) had grade 3 tumors, 3 patients (27.3{\%}) had grade 2 tumors, and 1 patient (9.1{\%}) had a grade 1 tumor. Four patients without children underwent fertility-sparing surgery, and 7 patients had full staging surgery, including a hysterectomy and bilateral salpingo-oophorectomy, with a laparoscopic approach used in 3. Eight patients underwent pelvic lymph node dissection, and 8 patients were administered adjuvant chemotherapy consisting of bleomycin, etoposide, and cisplatin in 6 cases, a modified bleomycin, etoposide, and cisplatin regimen in 1 case, and a combined paclitaxel and cisplatin regimen in 1 case. Two patients died of disease and were re-diagnosed with Sertoli form endometrioid carcinoma. The other patients remain alive without recurrence at the time of reporting. Conclusion Our findings suggest that regardless of tumor stage or grade, ovarian SLCT patients have a good prognosis. Close observation and unilateral salpingo-oophorectomy would be beneficial for women who still wish to have children, while hysterectomy and bilateral salpingo-oophorectomy with adjuvant chemotherapy would be the optimal treatment in other cases. Furthermore, meticulous pathologic diagnosis is needed to develop a precise treatment strategy.",
author = "Nam, {Seon Mi} and Kim, {Jee Whan} and Eoh, {Kyung Jin} and Kim, {Hye Min} and Lee, {Jung Yun} and Nam, {Eun Ji} and Sunghoon Kim and Kim, {Sang Wun} and YoungTae Kim",
year = "2017",
month = "1",
day = "1",
doi = "10.5468/ogs.2017.60.1.39",
language = "English",
volume = "60",
pages = "39--45",
journal = "Obstetrics and Gynecology Science",
issn = "2287-8572",
publisher = "Korean Society of Obstetrics and Gynecology",
number = "1",

}

A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution. / Nam, Seon Mi; Kim, Jee Whan; Eoh, Kyung Jin; Kim, Hye Min; Lee, Jung Yun; Nam, Eun Ji; Kim, Sunghoon; Kim, Sang Wun; Kim, YoungTae.

In: Obstetrics and Gynecology Science, Vol. 60, No. 1, 01.01.2017, p. 39-45.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution

AU - Nam, Seon Mi

AU - Kim, Jee Whan

AU - Eoh, Kyung Jin

AU - Kim, Hye Min

AU - Lee, Jung Yun

AU - Nam, Eun Ji

AU - Kim, Sunghoon

AU - Kim, Sang Wun

AU - Kim, YoungTae

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective To evaluate the clinical and pathologic characteristics of patients who were diagnosed with ovarian Sertoli-Leydig cell tumors (SLCTs) in a single institution. Methods The medical records of 11 patients who were pathologically diagnosed with SLCTs beginning in 1995 in a single institute was reviewed. Results The median patient age was 31 years (range, 16 to 70 years). Patient International Federation of Gynecology and Obstetrics stages were IA, IC, and IIB in 3 (27.3%), 6 (54.5%), and 2 (18.2%) patients, respectively. Six patients (54.5%) had grade 3 tumors, 3 patients (27.3%) had grade 2 tumors, and 1 patient (9.1%) had a grade 1 tumor. Four patients without children underwent fertility-sparing surgery, and 7 patients had full staging surgery, including a hysterectomy and bilateral salpingo-oophorectomy, with a laparoscopic approach used in 3. Eight patients underwent pelvic lymph node dissection, and 8 patients were administered adjuvant chemotherapy consisting of bleomycin, etoposide, and cisplatin in 6 cases, a modified bleomycin, etoposide, and cisplatin regimen in 1 case, and a combined paclitaxel and cisplatin regimen in 1 case. Two patients died of disease and were re-diagnosed with Sertoli form endometrioid carcinoma. The other patients remain alive without recurrence at the time of reporting. Conclusion Our findings suggest that regardless of tumor stage or grade, ovarian SLCT patients have a good prognosis. Close observation and unilateral salpingo-oophorectomy would be beneficial for women who still wish to have children, while hysterectomy and bilateral salpingo-oophorectomy with adjuvant chemotherapy would be the optimal treatment in other cases. Furthermore, meticulous pathologic diagnosis is needed to develop a precise treatment strategy.

AB - Objective To evaluate the clinical and pathologic characteristics of patients who were diagnosed with ovarian Sertoli-Leydig cell tumors (SLCTs) in a single institution. Methods The medical records of 11 patients who were pathologically diagnosed with SLCTs beginning in 1995 in a single institute was reviewed. Results The median patient age was 31 years (range, 16 to 70 years). Patient International Federation of Gynecology and Obstetrics stages were IA, IC, and IIB in 3 (27.3%), 6 (54.5%), and 2 (18.2%) patients, respectively. Six patients (54.5%) had grade 3 tumors, 3 patients (27.3%) had grade 2 tumors, and 1 patient (9.1%) had a grade 1 tumor. Four patients without children underwent fertility-sparing surgery, and 7 patients had full staging surgery, including a hysterectomy and bilateral salpingo-oophorectomy, with a laparoscopic approach used in 3. Eight patients underwent pelvic lymph node dissection, and 8 patients were administered adjuvant chemotherapy consisting of bleomycin, etoposide, and cisplatin in 6 cases, a modified bleomycin, etoposide, and cisplatin regimen in 1 case, and a combined paclitaxel and cisplatin regimen in 1 case. Two patients died of disease and were re-diagnosed with Sertoli form endometrioid carcinoma. The other patients remain alive without recurrence at the time of reporting. Conclusion Our findings suggest that regardless of tumor stage or grade, ovarian SLCT patients have a good prognosis. Close observation and unilateral salpingo-oophorectomy would be beneficial for women who still wish to have children, while hysterectomy and bilateral salpingo-oophorectomy with adjuvant chemotherapy would be the optimal treatment in other cases. Furthermore, meticulous pathologic diagnosis is needed to develop a precise treatment strategy.

UR - http://www.scopus.com/inward/record.url?scp=85028365371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028365371&partnerID=8YFLogxK

U2 - 10.5468/ogs.2017.60.1.39

DO - 10.5468/ogs.2017.60.1.39

M3 - Article

AN - SCOPUS:85028365371

VL - 60

SP - 39

EP - 45

JO - Obstetrics and Gynecology Science

JF - Obstetrics and Gynecology Science

SN - 2287-8572

IS - 1

ER -